Literature DB >> 9435312

Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts.

R Ciubotariu1, Z Liu, A I Colovai, E Ho, S Itescu, S Ravalli, M A Hardy, R Cortesini, E A Rose, N Suciu-Foca.   

Abstract

The role of the indirect allorecognition pathway in acute allograft rejection has been documented both in organ recipients and in experimental models. However, it is unknown whether self-restricted recognition of donor alloantigens also contributes to chronic allograft rejection. The aim of this study was to determine the relationship between allopeptide reactivity, epitope spreading, and chronic rejection. Using synthetic peptides corresponding to the hypervariable region of 32 HLA-DR alleles, we have followed the specificity of self-restricted T cell alloresponses to the donor in a population of 34 heart allograft recipients. T cells from sequential samples of blood collected from the patients up to 36 mo after transplantation were studied in limiting dilution analysis for allopeptide reactivity. The incidence of coronary artery vasculopathy (CAV) was significantly higher in patients who displayed persistent alloreactivity late after transplantation than in patients who showed no alloreactivity after the first 6 mo after transplantation. Both intra- and intermolecular spreading of epitopes was observed with an increased frequency in patients developing CAV in less than 2 yr, compared with patients without CAV; this suggests that diversification of the immune response against the graft contributes to chronic rejection. These data provide a strategy for identifying patients at risk of developing CAV and a rationale for therapeutic intervention aimed to prevent the progression of the rejection process.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9435312      PMCID: PMC508579          DOI: 10.1172/JCI1117

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  50 in total

1.  Endothelial adhesion molecules in heart transplantation.

Authors:  M D Allen; T O McDonald; T Carlos; V Himes; D Fishbein; S Aziz; D Gordon
Journal:  J Heart Lung Transplant       Date:  1992 May-Jun       Impact factor: 10.247

2.  Heterogeneity in antigen processing by different types of antigen-presenting cells. Effect of cell culture on antigen processing ability.

Authors:  L Vidard; K L Rock; B Benacerraf
Journal:  J Immunol       Date:  1992-09-15       Impact factor: 5.422

3.  The role of anti-HLA antibodies in heart transplantation.

Authors:  N Suciu-Foca; E Reed; C Marboe; P Harris; P X Yu; Y K Sun; E Ho; E Rose; K Reemtsma; D W King
Journal:  Transplantation       Date:  1991-03       Impact factor: 4.939

4.  Growth factors and cell proliferation in human transplant arteriosclerosis.

Authors:  D Gordon
Journal:  J Heart Lung Transplant       Date:  1992 May-Jun       Impact factor: 10.247

Review 5.  Cardiac allograft vasculopathy: relationship with acute cellular rejection and histocompatibility.

Authors:  M R Costanzo-Nordin
Journal:  J Heart Lung Transplant       Date:  1992 May-Jun       Impact factor: 10.247

6.  Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients.

Authors:  E A Rose; P Pepino; M L Barr; C R Smith; A J Ratner; E Ho; C Berger
Journal:  J Heart Lung Transplant       Date:  1992 May-Jun       Impact factor: 10.247

7.  MHC class II binding of peptides derived from HLA-DR 1.

Authors:  P E Harris; Z Liu; N Suciu-Foca
Journal:  J Immunol       Date:  1992-04-01       Impact factor: 5.422

8.  Cardiac allograft vasculopathy. Preferential regulation of endothelial cell-derived mesenchymal growth factors in response to a donor-specific cell-mediated allogeneic response.

Authors:  J D Hosenpud; T E Morris; G D Shipley; K A Mauck; C R Wagner
Journal:  Transplantation       Date:  1996-03-27       Impact factor: 4.939

9.  Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses.

Authors:  R I Lechler; T Heaton; L Barber; V Bal; J R Batchelor; G Lombardi
Journal:  Immunol Lett       Date:  1992-09       Impact factor: 3.685

Review 10.  Towards understanding the pathophysiology of chronic rejection.

Authors:  P Häyry; A Mennander; S Yilmaz; J Ustinov; A Räisänen; A Miettinen; I Lautenschlager; K Lemström; C A Bruggeman; T Paavonen
Journal:  Clin Investig       Date:  1992-09
View more
  49 in total

1.  Contributions of direct and indirect alloresponses to chronic rejection of kidney allografts in nonhuman primates.

Authors:  Ognjenka Nadazdin; Svjetlan Boskovic; Siew-Lin Wee; Hiroshi Sogawa; Ichiro Koyama; Robert B Colvin; R Neal Smith; Georges Tocco; David H O'Connor; Julie A Karl; Joren C Madsen; David H Sachs; Tatsuo Kawai; A Benedict Cosimi; Gilles Benichou
Journal:  J Immunol       Date:  2011-09-28       Impact factor: 5.422

2.  Prolongation of cardiac allograft survival by systemic administration of immature recipient dendritic cells deficient in NF-kappaB activity.

Authors:  Mao-Meng Tiao; Lina Lu; Ran Tao; Lianfu Wang; John J Fung; Shiguang Qian
Journal:  Ann Surg       Date:  2005-03       Impact factor: 12.969

Review 3.  Monitoring T cell alloreactivity after organ transplantation.

Authors:  J A Bradley; E M Bolton; G Pettigrew
Journal:  Clin Exp Immunol       Date:  2005-11       Impact factor: 4.330

Review 4.  Mechanisms of chronic rejection in cardiothoracic transplantation.

Authors:  Matthew J Weiss; Joren C Madsen; Bruce R Rosengard; James S Allan
Journal:  Front Biosci       Date:  2008-01-01

5.  Anticardiac myosin immunity and chronic allograft vasculopathy in heart transplant recipients.

Authors:  Safa Kalache; Rajani Dinavahi; Sean Pinney; Anita Mehrotra; Madeleine W Cunningham; Peter S Heeger
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 6.  Lung transplantation: infection, inflammation, and the microbiome.

Authors:  Takeshi Nakajima; Vyachesav Palchevsky; David L Perkins; John A Belperio; Patricia W Finn
Journal:  Semin Immunopathol       Date:  2011-01-27       Impact factor: 9.623

7.  Antibodies reactive to non-HLA antigens in transplant glomerulopathy.

Authors:  Rajani Dinavahi; Ajish George; Anne Tretin; Enver Akalin; Scott Ames; Jonathan S Bromberg; Graciela Deboccardo; Nicholas Dipaola; Susan M Lerner; Anita Mehrotra; Barbara T Murphy; Tibor Nadasdy; Estela Paz-Artal; Daniel R Salomon; Bernd Schröppel; Vinita Sehgal; Ravi Sachidanandam; Peter S Heeger
Journal:  J Am Soc Nephrol       Date:  2011-05-12       Impact factor: 10.121

8.  Early acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.

Authors:  Beata Mierzejewska; Paul M Schroder; Caitlin E Baum; Annette Blair; Connie Smith; Rene J Duquesnoy; Marilyn Marrari; Amira Gohara; Deepak Malhotra; Dinkar Kaw; Robert Liwski; Michael A Rees; Stanislaw Stepkowski
Journal:  Hum Immunol       Date:  2014-04-19       Impact factor: 2.850

9.  FasL expression in hepatic antigen-presenting cells and phagocytosis of apoptotic T cells by FasL+ Kupffer cells are indicators of rejection activity in human liver allografts.

Authors:  Aya Miyagawa-Hayashino; Tatsuaki Tsuruyama; Hiroto Egawa; Hironori Haga; Hiromi Sakashita; Tomoko Okuno; Shinya Toyokuni; Keiji Tamaki; Hirohiko Yamabe; Toshiaki Manabe; Shinji Uemoto
Journal:  Am J Pathol       Date:  2007-09-06       Impact factor: 4.307

Review 10.  Mechanism of cellular rejection in transplantation.

Authors:  Elizabeth Ingulli
Journal:  Pediatr Nephrol       Date:  2010-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.